⌘K

Home/Filings/4/0001104659-20-074359

4//SEC Filing

Zhou Quan 4

Accession 0001104659-20-074359

CIK 0000895051other

View on SEC.gov Company Profile

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 6:07 AM ET

Size

5.4 KB

Accession

0001104659-20-074359

Insider Transaction Report

Form 4

Period: 2020-06-16

CASI Pharmaceuticals, Inc.CASI

Director10% Owner

Transactions

Award
Stock Option (Right to Buy)
2020-06-16+67,429→ 67,429 total
Exercise: $2.63Exp: 2030-06-16→ Common Stock (67,429 underlying)

Footnotes (1)

[F1]Stock option award will vest ratably quarterly to the end of the year.

Documents

1 file

4
tm2022841d5_form4.xmlPrimary
FORM 4

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001491503

Filing Metadata

Form type: 4
Filed: Jun 17, 8:00 PM ET
Accepted: Jun 18, 6:07 AM ET
Size: 5.4 KB

View on SEC.gov